title: Immunohistochemistry on needle biopsies of childhood malignancies.
abstract: Ultrasound-guided percutaneous needle biopsy proved to be a reliable and safe method to obtain material for histopathological and immunohistochemical diagnosis prior to treatment in childhood malignancies. A principal tumour identification could be obtained by a combined morphological and phenotypic examination of 38 small-sized tumour biopsy specimens using a fairly limited panel of immunological reagents, including antibodies to leucocyte common antigen (CD 45), certain B- and T-cell markers, various intermediate filaments (cytokeratin, desmin and vimentin), and neuroblastoma cells (UJ 167.11, A2B5, and UJ 13A; the latter recognizes NCAM). Five undifferentiated neuroblastomas were all positive with the neuroblastoma antibodies but negative for the other markers, including vimentin. The negative reactivity for desmin and vimentin was the major immunohistochemical distinction between neuroblastomas and rhabdomyosarcomas. In addition, limited reactivity with the neuroblastoma antibodies was seen in blastematous parts of Wilms' tumour, duct-like structures in a hepatoblastoma, and in tumour cells in a few undifferentiated myelo- and lympho-proliferative lesions. This study shows the importance of a combined evaluation of morphology and the pattern of immunoreactivity employing multiple markers.
authors.affiliation: Institute of Pathology, University of Oslo, National Hospital, Norway.
authors.forename: B
authors.initials: B
authors.lastname: Roald
authors.forename: P
authors.initials: P
authors.lastname: Brandtzaeg
mesh_terms: D000911:Antibodies, Monoclonal; D015703:Antigens, CD / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D001707:Biopsy, Needle / Q000592:standards; D002648:Child; D002675:Child, Preschool; D003893:Desmin / Q000032:analysis; D003937:Diagnosis, Differential; D005455:Fluorescent Antibody Technique; D006649:Histocompatibility Antigens / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry; D007633:Keratins / Q000032:analysis; D017493:Leukocyte Common Antigens; D008232:Lymphoproliferative Disorders / Q000175:diagnosis* / Q000473:pathology; D009447:Neuroblastoma / Q000737:chemistry / Q000175:diagnosis* / Q000473:pathology; D012208:Rhabdomyosarcoma / Q000737:chemistry / Q000175:diagnosis* / Q000473:pathology; D014746:Vimentin / Q000032:analysis; D009396:Wilms Tumor / Q000737:chemistry / Q000175:diagnosis* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D014408:Biomarkers, Tumor; D003893:Desmin; D006649:Histocompatibility Antigens; D014746:Vimentin; D007633:Keratins; D017493:Leukocyte Common Antigens